Clearfield, Inc. (CLFD) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-08

Key Insights

Chief Commercial Officer Anis Khemakhem sold 635 shares at $30.28 per share on May 6, 2026, reducing his direct beneficial ownership from approximately 27,445 shares to 26,810 shares.
The sale was executed through tax withholding on vesting of restricted stock granted on May 9, 2024, indicating a routine equity compensation event rather than a discretionary sale decision by the executive.
As Chief Commercial Officer, this insider transaction is relatively modest in scale and appears to be a non-discretionary tax obligation event, which typically carries minimal negative sentiment regarding company prospects.

Want the newest filings?

This analysis covers the filing from 2026-05-08. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-02

Kathleen Skarvan, a director of Clearfield, Inc., acquired 2,544 shares of the company's common stock at $0 per share, increasing her direct ownership to 2,870 shares.
The acquisition of restricted stock by a director suggests potential confidence in the company's future performance and alignment of interests between management and shareholders.
Investors should monitor insider trading patterns, as they can provide insights into the management's views on the company's prospects.

Filed: 2026-03-02

Carol Ann Wirsbinski, a director of Clearfield, Inc. (CLFD), acquired 2,544 shares of the company's common stock on February 27, 2026 at no cost, increasing her direct beneficial ownership to 9,631 shares.
The restricted stock acquired by Wirsbinski has vesting restrictions that will lapse on the first business day prior to the 2027 Annual Meeting of Shareholders, indicating her long-term commitment to the company.
Insider transactions, such as this acquisition of shares by a director, can provide insight into management's confidence in the company's future prospects and may be seen as a positive signal for investors.

Filed: 2026-03-02

Insider Catherine T. Kelly acquired 2,544 shares of Clearfield, Inc. (CLFD) stock on 2/27/2026 at $0 per share, increasing her direct ownership to 5,317 shares.
The restricted stock held by Kelly has vesting restrictions until the first business day prior to the 2027 Annual Meeting of Shareholders.
The insider transaction suggests Kelly is bullish on Clearfield's prospects and could indicate confidence in the company's future performance.

Filed: 2026-03-02

Walter L. Jones, Jr., a director of Clearfield, Inc. (CLFD), has acquired 2,544 shares of the company's common stock at a price of $0 per share.
This transaction suggests that Jones has confidence in the company's future performance and is increasing his stake as a director.
The timing of this transaction, shortly before the 2027 Annual Meeting of Shareholders, may indicate that Jones expects positive developments or news that could drive the stock price higher.

Filed: 2026-03-02

Ademir Sarcevic, a director of Clearfield, Inc., has acquired 2,544 shares of the company's common stock on February 27, 2026, increasing his direct ownership to 5,317 shares.
The acquisition of shares by a director suggests their positive outlook on the company's future prospects and aligns their interests with shareholders.
The timing of the acquisition, just prior to the company's annual meeting, may indicate that the director believes the stock is undervalued and presents an attractive investment opportunity.

Filed: 2026-03-02

Ronald G. Roth, a director and 10% owner of Clearfield, Inc. (CLFD), acquired 2,544 shares of common stock on February 27, 2026, indicating continued confidence in the company.
Roth now holds a direct ownership of 1,281,808 shares and an indirect ownership of 176,760 shares through his spouse, representing a significant stake in the company.
The acquisition of shares by an insider could signal positive sentiment about the company's future prospects and growth potential.

Filed: 2026-03-02

The reporting person, Rebecca Seidel, acquired 2,544 shares of Clearfield, Inc. (CLFD) common stock, increasing her direct beneficial ownership to 2,870 shares.
The shares were acquired with no cost, likely through an equity compensation plan, as the transaction price is listed as $0.
The restrictions on the acquired restricted stock will lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.

Filed: 2026-02-20

Donald R. Hayward, a director of Clearfield, Inc. (CLFD), sold 3,595 shares of the company's common stock on February 19, 2026 at an average price of $32 per share.
The sale represents a relatively small portion of Hayward's total ownership in the company, which remains at 10,870 shares.
Insider selling can sometimes indicate a lack of confidence in the company's future prospects, but the size and timing of this transaction do not suggest a significant concern.

Filed: 2026-01-05

The Chief Financial Officer, Daniel Herzog, acquired 88 shares of Clearfield, Inc. (CLFD) common stock through the company's Employee Stock Purchase Plan (ESPP) on December 31, 2025.
Herzog's ESPP purchase was made at a discounted price of $24.78 per share, indicating his confidence in the company's future performance.
This transaction increases Herzog's direct beneficial ownership of CLFD common stock to 85,082 shares, demonstrating his ongoing commitment to the company.

Filed: 2026-01-05

John P. Hill, the Chief Operating Officer of Clearfield, Inc. (CLFD), acquired 222 shares of the company's common stock through the Employee Stock Purchase Plan (ESPP) on December 31, 2025.
This transaction increased Hill's direct ownership of CLFD shares to 192,215, indicating his continued confidence in the company's prospects.
Insider purchases can signal management's belief in the company's future performance and may be viewed positively by investors.

Other reports for Clearfield, Inc.

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.